14th February 2019: Dr Antoinette Perry receiving official award of Commercialisation Fund from Deirdre Glenn, Director, Lifesciences & Food Commercialisation at Enterprise Ireland for project entitled, “epiCaPture: a urine test to detect aggressive prostate cancer”.
-
Cancer Research News- Analysis identifies 50 new genomic regions associated with kidney cancer risk April 26, 2024
- NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients April 18, 2024
- For childhood cancer survivors, inherited genetic factors influence risk of cancers later in life March 7, 2024
- Cancer Grand Challenges selects five new global, interdisciplinary teams to take on four challenges March 6, 2024
- NIH to address dwindling clinical trial patient enrollment with centralized staffing support February 29, 2024
- NIH launches research network to evaluate emerging cancer screening technologies February 21, 2024
- W. Kimryn Rathmell begins work as 17th director of the National Cancer Institute December 18, 2023
- NCI researchers develop approach that could help supercharge T-cell therapies against solid tumors November 1, 2023
- NIH immunotherapy pioneer Steven Rosenberg awarded nation’s highest honor for technology and innovation October 24, 2023
- Annual Report to the Nation Part 2: New cancer diagnoses fell abruptly early in the COVID-19 pandemic September 27, 2023